A Randomized, Double Blind Placebo-controlled Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia in Patients With Solid Tumor
Phase of Trial: Phase III
Latest Information Update: 04 Oct 2019
Price : $35 *
At a glance
- Drugs Eltrombopag (Primary)
- Indications Solid tumours; Thrombocytopenia
- Focus Therapeutic Use
- 16 Oct 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2019.
- 16 Oct 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2019.
- 16 May 2014 New trial record